Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $76.64 (-2.9%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 38%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/3/2022 Raymond James Dane Leone Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 75.07
(78.96)		 5.18% Details
5/2/2022 CFRA N/A Downgrade Sell
(Hold)		 66.00
(N/A)		 77.20
(78.96)		 2.28% Details
Like BMY Ratings? Also take a look at CELG, NKTR, TPTX, EAR

BMY Ratings News